Clinical Trials
176 trialsOCTANE
University Health Network, Toronto
A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy
Memorial Sloan Kettering Cancer Center
IPRICE
Centre Paul Strauss
RADIO-PBM
Centre Paul Strauss
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
TIMED
UNC Lineberger Comprehensive Cancer Center
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Case Comprehensive Cancer Center
EDS01 HN
West China Hospital
COPD Care Pathway Among Patients With Cancer
Wake Forest University Health Sciences
ESSI-SURG
University Health Network, Toronto
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Washington University School of Medicine
Specialist Nurse-Led Nursing Management for Patients Undergoing Head and Neck Cancer Surgery
Tianjin Medical University Cancer Institute and Hospital
The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer
University of Oklahoma
Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease
Memorial Sloan Kettering Cancer Center
Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
University of Cincinnati
First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
Wake Forest University Health Sciences
DeEscO
University of Zurich
Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
University of California, San Francisco
BRIDGE
Sun Yat-sen University
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
University of Arkansas
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
Roswell Park Cancer Institute
Trop2-targeted immunoPET Imaging of Solid Tumors
RenJi Hospital
RECOLOR-HN
Yale University
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
SCREEN-HPV
UNICANCER
MOHSAHRTSS
University of Vermont Medical Center
Smoking Cessation Treatment for Head & Neck Cancer Patients
M.D. Anderson Cancer Center
ORCA-2
University College, London
Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
Providence Health & Services
Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC
University of California, San Diego
Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)
University of Arizona
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients
M.D. Anderson Cancer Center
Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
M.D. Anderson Cancer Center
EACH
University College, London
ILLUMINE
Groupe Oncologie Radiotherapie Tete et Cou
LEARN
University of Sydney
CHIRP
University of Sydney
3D Specimen Maps for RT Planning
Vanderbilt University Medical Center
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
Universitaire Ziekenhuizen KU Leuven
H&NANCE
Istituto Italiano di Tecnologia
OvAR-Y
Washington University School of Medicine
GATEWAY
Sun Yat-sen University
MISORL
University Hospital, Bordeaux
Training Swallowing Initiation During Expiration
Northwestern University
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Peking University First Hospital
A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study
University of Chicago
NUTRIMAX
Centre Hospitalier Universitaire, Amiens
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors
West China Hospital